Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows
PR91289
MILAN, Aug. 31, 2021 /PRNewswire=KYODO JBN/ --
The number of solid organ transplants performed during the first wave of
COVID-19 in 2020 plunged by 31% compared to the previous year, according to a
new global study presented at the European Society for Organ Transplantation
(ESOT) Congress 2021 [https://www.esotcongress.org].
According to modelling calculations, the slowdown in transplants resulted in
more than 48,000 years of patient life loss.
The research leveraged data from 22 countries and revealed major variations in
the response of transplant programmes to the COVID-19 pandemic, with transplant
activity dropping by more than 90% in some countries.
Kidney transplantation showed the largest reduction across nearly all countries
during 2020 compared to 2019, with the study finding a decrease in living donor
kidney (-40%) and liver (-33%) transplants. For deceased donor transplants,
there was a reduction in kidney (-12%), liver (-9%), lung (-17%) and heart
(-5%) transplants.
The research, published today in the Lancet Public Health, highlighted how some
countries managed to sustain the rate of transplant procedures whilst others
experienced serious reductions in the number of transplants compared to the
previous year and, in some areas, living donor kidney and liver transplantation
ceased completely. Overall, there was a strong temporal association between
increased COVID-19 infection rate and reductions in deceased and living solid
organ transplants.
Dr Olivier Aubert, lead author of the study, commented, "The first wave of
COVID-19 had a devastating impact on the number of transplants across many
countries, affecting patient waiting lists and regrettably leading to a
substantial loss of life."
Professor Alexandre Loupy, head of the Paris Translational Research Center for
Organ Transplantation and study author, furthered, "Living donor
transplantation, which reduced more substantially, requires significant
resources and planning compared to deceased donors. This is extremely difficult
during a pandemic and there are also major ethical concerns for the safety of
the donor."
"It's clear that there are many indirect deaths associated with COVID-19 and
our study confirms that the pandemic has far-reaching consequences on many
medical specialties."
The estimated numbers of life-years lost were 37,664 years for patients
waitlisted for a kidney, 7,370 for a liver, 1,799 years for a lung, and 1,406
for a heart, corresponding to a total 48,239 life-years lost.
Source: European Society for Organ Transplantation (ESOT)
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。